Heidi Cuthbert

Macquarie Group (ASX:MQG) has poached Westpac (ASX:WBC) treasurer Jo Dawson for the equivalent role, marking another high-profile move in an intensifying talent shake-up across Australia's major banks.

L1 Group (ASX:L1G) reported total assets under management of $17.64 billion as of Dec. 31, 2025, up from $16.95 billion at Sept. 30, 2025.

Enlitic (ASX:ENL) has completed technical validation of its Ensight medical imaging data standardisation platform on Oracle Cloud Infrastructure, leveraging AMD EPYC processors.

Pivotal Metals (ASX:PVT) has reported results from its recent induced polarisation survey at the Lorraine mine target.

A major US crypto market-structure bill heads to Senate markup on January 15, putting regulation back at the top of the agenda.

TPG Capital is reportedly accelerating plans for a blockbuster return of Greencross to the ASX, with dealmakers targeting a valuation above $4 billion and a capital raising of more than $700 million before the end of March.

Paramount Skydance (NASDAQ:PSKY) escalated its hostile pursuit of Warner Bros. Discovery (NYSE:WBD) on Monday, filing a lawsuit in Delaware to force the disclosure of financial details surrounding Netflix's (NASDAQ:NFLX) $82.7 billion rival bid.

BioAge Labs (NASDAQ:BIOA) shares climbed Monday after the longevity-focused biotech reported that its experimental oral drug, BGE-102, sharply reduced systemic inflammation in a mid-stage study of obese patients.

Hyperfine (NASDAQ:HYPR), the medical technology firm behind the first portable, AI-powered brain imaging system, reported a dramatic surge in fourth-quarter revenue, signaling a potential turning point for its bedside MRI technology.

DexCom (NASDAQ:DXCM) projected its annual revenue will climb toward $5.25 billion in 2026, marking a pivotal year for the glucose-monitoring leader as it phases out older hardware in favor of its longest-lasting sensor technology to date.